Dechra Pharmaceuticals PLC/ GB0009633180 /
| 3/27/2023 11:32:28 AM | Chg. +22.00 | Volume | Bid11:34:23 AM | Ask11:34:40 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2,580.00GBX | +0.86% | 11,819 Turnover(GBP): 303,756.3200 |
2,578.00Bid Size: 34 | 2,582.00Ask Size: 122 | 2.78 bill.GBP | - | - |
Assets
| 2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 37.7000 | 45.2000 | 45.3000 | 58.4000 | 76.4000 | ||||||
| Intangible Assets | 360.4000 | 396.3000 | 709.8000 | 687 | 692.2000 | ||||||
| Long-Term Investments | 0.0000 | 10.9000 | 10.5000 | 10.1000 | 17.4000 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 54.4000 | 56.5000 | 86.6000 | 104 | 120.8000 | ||||||
| Accounts Receivable | 59.2000 | 59.7000 | 81.6000 | 99.9000 | 93.9000 | ||||||
| Cash and Cash Equivalents | 39.1000 | 61.2000 | 79.7000 | 80.3000 | 227.4000 | ||||||
| Current Assets | 162.5000 | 185 | 247.9000 | 292.1000 | 448.9000 | ||||||
| Total Assets | 560.8000 | 638.1000 | 1,017.3000 | 1,048.5000 | 1,237.6000 | ||||||
Liabilities
| 2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 24.3000 | 21.4000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 60.8000 | 55 | 105.5000 | 99.8000 | 90.7000 | ||||||
| Liabilities | 284.1000 | 335.4000 | 512.3000 | 539.4000 | 600.1000 | ||||||
| Share Capital | .9270 | .9320 | 1 | 1 | 1.1000 | ||||||
| Total Equity | 276.6000 | 302.6000 | 505 | 509.1000 | 637.5000 | ||||||
| Minority Interests | 2 | 1.6000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 560.8000 | 638.1000 | 1,017.3000 | 1,048.5000 | 1,237.6000 | ||||||
Income Statement
| 2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 247.6000 | 359.3000 | 407.1000 | 481.8000 | 515.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 19.5000 | 33.2000 | 34.1000 | 39 | 52.2000 | ||||||
| Interest Income | -4.9800 | -4.5000 | -4.9000 | -10.8000 | -11 | ||||||
| Income Before Taxes | 14.5000 | 28.6000 | 28.9000 | 27.8000 | 40.9000 | ||||||
| Income Taxes | 2 | 2.5000 | -7.2000 | -3.1000 | 7 | ||||||
| Minority Interests Profit | -.2000 | .0050 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 12.5000 | 26.1000 | 36.1000 | 30.9000 | 33.9000 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 43.6000 | 77.4000 | 64 | 81.8000 | 106.4000 | ||||||
| Cash Flow from Investing Activities | -174 | -57.3000 | -241.7000 | -61.9000 | -81.5000 | ||||||
| Cash Flow from Financing | 125.3000 | 1.6000 | 193.8000 | -20.1000 | 118.9000 | ||||||
| Decrease / Increase in Cash | -5.1000 | 21.7000 | 16.1000 | -.2000 | 143.8000 | ||||||
| Employees | 1,308 | 1,338 | 1,437 | 1,731 | 1,808 | ||||||